Cosme A et al. |
Antimicrobial susceptibility testing before first-line treatment for infection in patients with dual or triple antibiotic resistance. |
2017 |
World J. Gastroenterol. |
pmid:28566898
|
Choi HS et al. |
Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection. |
2012 |
World J. Gastroenterol. |
pmid:22654429
|
Kawakami E et al. |
Furazolidone-based triple therapy for H pylori gastritis in children. |
2006 |
World J. Gastroenterol. |
pmid:17006997
|
Ahmad N et al. |
Characterization of clarithromycin resistance in Malaysian isolates of Helicobacter pylori. |
2009 |
World J. Gastroenterol. |
pmid:19575497
|
Matta AJ et al. |
Punctual mutations in gene of clarithromycin-resistant in Colombian populations. |
2018 |
World J. Gastroenterol. |
pmid:29662291
|
Yoon JH et al. |
Trends in the eradication rates of Helicobacter pylori infection for eleven years. |
2012 |
World J. Gastroenterol. |
pmid:23236238
|
Buzás GM and Józan J |
First-line eradication of H pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2004. |
2006 |
World J. Gastroenterol. |
pmid:16981260
|
Chen SJ et al. |
Effect of H pylori infection and its eradication on hyperammo-nemia and hepatic encephalopathy in cirrhotic patients. |
2008 |
World J. Gastroenterol. |
pmid:18350632
|
Sugimoto M and Furuta T |
Efficacy of tailored Helicobacter pylori eradication therapy based on antibiotic susceptibility and CYP2C19 genotype. |
2014 |
World J. Gastroenterol. |
pmid:24914361
|
Heo J and Jeon SW |
Optimal treatment strategy for Helicobacter pylori: era of antibiotic resistance. |
2014 |
World J. Gastroenterol. |
pmid:24914324
|
Yilmaz O and Demiray E |
Clinical role and importance of fluorescence in situ hybridization method in diagnosis of H pylori infection and determination of clarithromycin resistance in H pylori eradication therapy. |
2007 |
World J. Gastroenterol. |
pmid:17278188
|
Onyekwere CA et al. |
Rabeprazole, clarithromycin, and amoxicillin Helicobacter pylori eradication therapy: report of an efficacy study. |
2014 |
World J. Gastroenterol. |
pmid:24707145
|
Wu JY et al. |
Detection of genotypic clarithromycin-resistant Helicobacter pylori by string tests. |
2014 |
World J. Gastroenterol. |
pmid:24695835
|
Riquelme A et al. |
Optimal length of triple therapy for H pylori eradication in a population with high prevalence of infection in Chile. |
2007 |
World J. Gastroenterol. |
pmid:17589948
|
Ersoy O et al. |
H pylori infection in patients with Behcet's disease. |
2007 |
World J. Gastroenterol. |
pmid:17589951
|
Salimi A et al. |
Toxicity of macrolide antibiotics on isolated heart mitochondria: a justification for their cardiotoxic adverse effect. |
2016 |
Xenobiotica |
pmid:26068526
|
Pan W et al. |
Effects of clopidogrel and clarithromycin on the disposition of sibutramine and its active metabolites M1 and M2 in relation to CYP2B6*6 polymorphism. |
2013 |
Xenobiotica |
pmid:22830954
|
Kanayama N et al. |
Drug-drug interactions in the metabolism of imidafenacin: role of the human cytochrome P450 enzymes and UDP-glucuronic acid transferases, and potential of imidafenacin to inhibit human cytochrome P450 enzymes. |
2007 |
Xenobiotica |
pmid:17484517
|
Burt HJ et al. |
IC50-based approaches as an alternative method for assessment of time-dependent inhibition of CYP3A4. |
2010 |
Xenobiotica |
pmid:20230210
|
Kubo JI et al. |
Pharmacokinetic evaluation of high pulmonary disposition of clarithromycin after systemic administration. |
2002 |
Xenobiotica |
pmid:12419017
|